Compare · CHE vs SHCR
CHE vs SHCR
Side-by-side comparison of Chemed Corp (CHE) and Sharecare Inc. (SHCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and SHCR operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $7.11B, about 7.0x SHCR ($1.02B).
- CHE has hit the wire 7 times in the past 4 weeks while SHCR has been quiet.
- Both have 6 recent analyst ratings on file.
- Company
- Chemed Corp
- Sharecare Inc.
- Price
- -
- -
- Market cap
- $7.11B
- $1.02B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 7
- 0
- Recent ratings
- 6
- 6
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Sharecare Inc.
Sharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects doctors, health plans, employers, health management tools, information, and others that enable individuals, workforces, and communities to improve their holistic well-being. The company was founded in 2009 and is headquartered in Atlanta, Georgia.
Latest CHE
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
- VP and Chief Legal Officer Judkins Brian C exercised 6,786 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 5,878 units of Capital Stock, increasing direct ownership by 37% to 3,344 units (SEC Form 4)
- CEO - Vitas Healthcare Wherley Joel L exercised 2,599 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 2,270 units of Capital Stock, increasing direct ownership by 39% to 1,181 units (SEC Form 4)
- Chemed Corporation Declares Quarterly Dividend of 70 Cents
- President and CEO Mcnamara Kevin J covered exercise/tax liability with 19,802 units of Capital Stock, sold $1,079,020 worth of Capital Stock (2,000 units at $539.51) and exercised 2,001 units of Capital Stock at a strike of $445.35, decreasing direct ownership by 22% to 70,418 units (SEC Form 4)
- Director Grace Patrick P sold $101,080 worth of Capital Stock (190 units at $532.00), decreasing direct ownership by 5% to 3,533 units (SEC Form 4)
- SEC Form 10-Q filed by Chemed Corp
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports Second-Quarter 2026 Results
Latest SHCR
- Sharecare wins 21 Digital Health Awards in Spring 2025 competition
- Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions
- Sharecare wins 17 Digital Health Awards in Fall 2024
- SEC Form 15-12G filed by Sharecare Inc.
- Amendment: Sharecare Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- Sharecare expands suite of interactive media solutions to engage, educate, and activate patients and providers
- Director Torraco Nicole returned 43,124 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Sagansky Jeffrey returned 927,011 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Allred Jeffrey A returned 705,385 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Goulet Kenneth R returned 428,999 shares to the company, closing all direct ownership in the company (SEC Form 4)